{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T03:34:10Z","timestamp":1790048050999,"version":"4.0.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T00:00:00Z","timestamp":1767484800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":30,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Lack of access to sterile supplies among people who use drugs contributes to increased rates of infectious disease transmission, including human immunodeficiency virus, hepatitis C virus, and sexually transmitted infections. People residing in California, United States Veterans, and those who have experienced homelessness are disproportionately impacted. Syringe services programs (SSPs) are vital to reducing these harms, but access may be limited by hours of operation, geographic barriers, need for in-person interaction, and stigma. Harm reduction vending machines (HRVMs) which often dispense sterile syringes and condoms are an evidence-based strategy to increase access; however, no studies have evaluated implementation or impacts among these populations. This cross-sectional, mixed-methods study aims to evaluate the first HRVM program designed for Veterans in California who experienced homelessness and reside in supportive housing buildings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We will recruit 40 Veteran residents and 20 staff (Veterans Affairs [VA] and housing staff) at six housing buildings with a co-located HRVM. Participants will provide informed consent, complete a standardized electronic questionnaire, semi-structured qualitative interview, and be compensated via Visa gift cards ($90 for Veterans; $60 for staff). Interview transcripts will be analyzed thematically using inductive coding. Program-level data will be collected from enrollment logs, facility records, and HRVM software to evaluate reach, effectiveness, adoption, implementation, and maintenance (RE-AIM).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Findings will provide essential evidence on how HRVMs may reduce longstanding access barriers and expand delivery of life-saving harm reduction supplies to underserved Veterans. This study is the first to evaluate HRVMs in Veterans supportive housing and among this population disproportionately affected by substance use, stigma, and homelessness. Results may inform the expansion of community-based and VA SSPs nationwide. Study strengths include a theory-informed design, real-world implementation data, and attention to user and staff experiences. Limitations include reliance on self-report data, lack of a control group, and limited generalizability beyond Veterans. Future research may examine long-term health outcomes, cost-effectiveness, and feasibility of HRVMs scaled up in diverse settings. Findings from this study may guide policymakers and public health practitioners in integrating HRVMs into broader harm reduction strategies to prevent overdose, infections, and other adverse outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12954-025-01385-8","type":"journal-article","created":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T07:04:49Z","timestamp":1767510289000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Evaluating the implementation and impact of harm reduction vending machines in veterans supportive housing settings: a mixed-methods study protocol"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5397-3012","authenticated-orcid":false,"given":"Tessa","family":"Rife-Pennington","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8517-6678","authenticated-orcid":false,"given":"Michael P.","family":"Douglas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6194-7650","authenticated-orcid":false,"given":"Nikki Kalani","family":"Apana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6057-9590","authenticated-orcid":false,"given":"Sree","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7406-0661","authenticated-orcid":false,"given":"David L.","family":"Pennington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,4]]},"reference":[{"key":"1385_CR1","unstructured":"De Sousa T, Andrichik A, Cuellar M et al. The 2022 annual homelessness assessment report (AHAR) to congress, part 1: point-in-time estimates to congress. The U.S. department of housing and urban development, office of community planning and development. [https:\/\/www.huduser.gov\/portal\/sites\/default\/files\/pdf\/2022-ahar-part-1.pdf]."},{"key":"1385_CR2","unstructured":"San Francisco homeless count and survey 2022 comprehensive report. Applied survey research (ASR). [https:\/\/hsh.sfgov.org\/wp-content\/uploads\/2022\/08\/2022-PIT-Count-Report-San-Francisco-Updated-8.19.22.pdf ]."},{"key":"1385_CR3","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1111\/ajad.12289","volume":"24","author":"EM Dunne","year":"2015","unstructured":"Dunne EM, Burrell LE 2nd, Diggins AD, Whitehead NE, Latimer WW. Increased risk for substance use and health-related problems among homeless veterans. Am J Addict. 2015;24:676\u201380.","journal-title":"Am J Addict"},{"key":"1385_CR4","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1093\/epirev\/mxu004","volume":"37","author":"J Tsai","year":"2015","unstructured":"Tsai J, Rosenheck RA. Risk factors for homelessness among US veterans. Epidemiol Rev. 2015;37:177\u201395.","journal-title":"Epidemiol Rev"},{"key":"1385_CR5","doi-asserted-by":"publisher","first-page":"109296","DOI":"10.1016\/j.drugalcdep.2022.109296","volume":"233","author":"MR Begley","year":"2022","unstructured":"Begley MR, Ravindran C, Peltzman T, Morley SW, Stephens BM, Ashrafioun L, McCarthy JF. Veteran drug overdose mortality, 2010\u20132019. Drug Alcohol Depend. 2022;233:109296.","journal-title":"Drug Alcohol Depend"},{"key":"1385_CR6","doi-asserted-by":"publisher","first-page":"108791","DOI":"10.1016\/j.drugalcdep.2021.108791","volume":"225","author":"KJ Hoggatt","year":"2021","unstructured":"Hoggatt KJ, Harris AHS, Washington DL, Williams EC. Prevalence of substance use and substance-related disorders among US veterans health administration patients. Drug Alcohol Depend. 2021;225:108791.","journal-title":"Drug Alcohol Depend"},{"key":"1385_CR7","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.addbeh.2013.02.002","volume":"39","author":"J Tsai","year":"2014","unstructured":"Tsai J, Kasprow WJ, Rosenheck RA. Alcohol and drug use disorders among homeless veterans: prevalence and association with supported housing outcomes. Addict Behav. 2014;39:455\u201360.","journal-title":"Addict Behav"},{"key":"1385_CR8","unstructured":"California department of public health. California overdose surveillance dashboard. [https:\/\/skylab.cdph.ca.gov\/ODdash\/?tab=Home]."},{"key":"1385_CR9","doi-asserted-by":"publisher","first-page":"108797","DOI":"10.1016\/j.drugalcdep.2021.108797","volume":"225","author":"A Hotton","year":"2021","unstructured":"Hotton A, Mackesy-Amiti ME, Boodram B. Trends in homelessness and injection practices among young urban and suburban people who inject drugs: 1997\u20132017. Drug Alcohol Depend. 2021;225:108797.","journal-title":"Drug Alcohol Depend"},{"key":"1385_CR10","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1097\/OLQ.0000000000000780","volume":"45","author":"SP Williams","year":"2018","unstructured":"Williams SP, Bryant KL. Sexually transmitted infection prevalence among homeless adults in the united states: a systematic literature review. Sex Transm Dis. 2018;45:494\u2013504.","journal-title":"Sex Transm Dis"},{"key":"1385_CR11","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/S1473-3099(12)70177-9","volume":"12","author":"U Beijer","year":"2012","unstructured":"Beijer U, Wolf A, Fazel S. Prevalence of tuberculosis, hepatitis C virus, and HIV in homeless people: a systematic review and meta-analysis. Lancet Infect Dis. 2012;12:859\u201370.","journal-title":"Lancet Infect Dis"},{"key":"1385_CR12","doi-asserted-by":"publisher","first-page":"e309","DOI":"10.1016\/S2468-2667(21)00013-X","volume":"6","author":"C Arum","year":"2021","unstructured":"Arum C, Fraser H, Artenie AA, Bivegete S, Trickey A, Alary M, Astemborski J, Iversen J, Lim AG, MacGregor L, et al. Homelessness, unstable housing, and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis. Lancet Public Health. 2021;6:e309\u201323.","journal-title":"Lancet Public Health"},{"key":"1385_CR13","doi-asserted-by":"publisher","first-page":"ofac175","DOI":"10.1093\/ofid\/ofac175","volume":"9","author":"D Partida","year":"2022","unstructured":"Partida D, Powell J, Gonzalez D, Khalili M. Gaps in hepatitis A and hepatitis B vaccination among hepatitis C antibody-positive individuals experiencing homelessness. Open Forum Infect Dis. 2022;9:ofac175.","journal-title":"Open Forum Infect Dis"},{"key":"1385_CR14","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1093\/cid\/cix295","volume":"65","author":"AJ Noska","year":"2017","unstructured":"Noska AJ, Belperio PS, Loomis TP, O\u2019Toole TP, Backus LI. Prevalence of human immunodeficiency virus, hepatitis C virus, and hepatitis B virus among homeless and nonhomeless united States veterans. Clin Infect Dis. 2017;65:252\u20138.","journal-title":"Clin Infect Dis"},{"key":"1385_CR15","unstructured":"The 2024 annual homelessness assessment report (AHAR) to Congress: Part 1: Point-in-time estimates of homelessness. 2024. [https:\/\/www.huduser.gov\/portal\/sites\/default\/files\/pdf\/2024-AHAR-Part-1.pdf]."},{"key":"1385_CR16","unstructured":"HUD-VASH program provides comprehensive care for aging Veterans facing homelessness. VA San Francisco Health Care Stories. [https:\/\/www.va.gov\/san-francisco-health-care\/stories\/hud-vash-program-provides-comprehensive-care-for-aging-veterans-facing-homelessness\/]."},{"key":"1385_CR17","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.15585\/mmwr.mm6448a3","volume":"64","author":"DC Des Jarlais","year":"2015","unstructured":"Des Jarlais DC, Nugent A, Solberg A, Feelemyer J, Mermin J, Holtzman D. Syringe service programs for persons who inject drugs in urban, suburban, and rural areas\u2013United States, 2013. MMWR Morb Mortal Wkly Rep. 2015;64:1337\u201341.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"1385_CR18","doi-asserted-by":"crossref","unstructured":"Rife-Pennington T, Dinges E, Ho MQ. Implementing syringe services programs within the veterans health administration: facility experiences and next steps. J Am Pharm Assoc(2003). 2023;63:234\u2013240.","DOI":"10.1016\/j.japh.2022.10.019"},{"key":"1385_CR19","unstructured":"US department of veterans affairs: veterans benefits administration. Applying for benefits and your character of discharge. [https:\/\/www.benefits.va.gov\/benefits\/character_of_discharge.asp"},{"key":"1385_CR20","doi-asserted-by":"publisher","first-page":"108488","DOI":"10.1016\/j.jsat.2021.108488","volume":"130","author":"A Burgess","year":"2021","unstructured":"Burgess A, Bauer E, Gallagher S, Karstens B, Lavoie L, Ahrens K, O\u2019Connor A. Experiences of stigma among individuals in recovery from opioid use disorder in a rural setting: a qualitative analysis. J Subst Abuse Treat. 2021;130:108488.","journal-title":"J Subst Abuse Treat"},{"key":"1385_CR21","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12916-019-1250-8","volume":"17","author":"JC Kane","year":"2019","unstructured":"Kane JC, Elafros MA, Murray SM, Mitchell EMH, Augustinavicius JL, Causevic S, Baral SD. A scoping review of health-related stigma outcomes for high-burden diseases in low- and middle-income countries. BMC Med. 2019;17:17.","journal-title":"BMC Med"},{"key":"1385_CR22","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.drugalcdep.2013.02.018","volume":"131","author":"LC van Boekel","year":"2013","unstructured":"van Boekel LC, Brouwers EP, van Weeghel J, Garretsen HF. Stigma among health professionals towards patients with substance use disorders and its consequences for healthcare delivery: systematic review. Drug Alcohol Depend. 2013;131:23\u201335.","journal-title":"Drug Alcohol Depend"},{"key":"1385_CR23","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1097\/ADM.0000000000001145","volume":"17","author":"SG Weiner","year":"2023","unstructured":"Weiner SG, Lo YC, Carroll AD, Zhou L, Ngo A, Hathaway DB, Rodriguez CP, Wakeman SE. The incidence and disparities in use of stigmatizing language in clinical notes for patients with substance use disorder. J Addict Med. 2023;17:424\u201330.","journal-title":"J Addict Med"},{"key":"1385_CR24","unstructured":"Rife-Pennington T, Thao, Vu TT, Burbank S, Furnas W, Montalvo P, Hunt A. Harm reduction services for veterans in supportive housing: comparing outreach approaches. In AMERSA National Conference; 2023."},{"key":"1385_CR25","unstructured":"Vu TT, Rife-Pennington T. Increasing harm reduction services for veterans in supportive housing. In Western States Conference; 2023."},{"key":"1385_CR26","unstructured":"Vu TT, Rife-Pennington T. Evaluating a pharmacist-led initiative to increase harm reduction services access in a high-risk housing facility for homeless veterans. ASHP midyear clinical meeting. Residents & Fellow Posters; 2022."},{"key":"1385_CR27","doi-asserted-by":"crossref","first-page":"89","DOI":"10.9740\/mhc.2022.04.089","volume":"12","author":"T Rife-Pennington","year":"2022","unstructured":"Rife-Pennington T, Allehyari A, Barajas A. Implementing a harm reduction kit pilot program for unstably housed veterans. Mental Health Clinician. 2022;12:89\u2013174.","journal-title":"Mental Health Clinician"},{"key":"1385_CR28","doi-asserted-by":"publisher","first-page":"2692","DOI":"10.1080\/07853890.2022.2121418","volume":"54","author":"ST Allen","year":"2022","unstructured":"Allen ST, O\u2019Rourke A, Johnson JA, Cheatom C, Zhang Y, Delise B, Watkins K, Reich K, Reich R, Lockett C. Evaluating the impact of naloxone dispensation at public health vending machines in Clark County, Nevada. Ann Med. 2022;54:2692\u2013700.","journal-title":"Ann Med"},{"key":"1385_CR29","doi-asserted-by":"crossref","unstructured":"Arendt D. Expanding the accessibility of harm reduction services in the United States: Measuring the impact of an automated harm reduction dispensing machine. J Am Pharm Assoc(2003). 2023;63:309\u2013316.","DOI":"10.1016\/j.japh.2022.10.027"},{"key":"1385_CR30","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1080\/09595230701711199","volume":"27","author":"M Islam","year":"2008","unstructured":"Islam M, Stern T, Conigrave KM, Wodak A. Client satisfaction and risk behaviours of the users of syringe dispensing machines: a pilot study. Drug Alcohol Rev. 2008;27:13\u20139.","journal-title":"Drug Alcohol Rev"},{"key":"1385_CR31","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.drugpo.2007.07.006","volume":"19","author":"M Islam","year":"2008","unstructured":"Islam M, Wodak A, Conigrave KM. The effectiveness and safety of syringe vending machines as a component of needle syringe programmes in community settings. Int J Drug Policy. 2008;19:436\u201341.","journal-title":"Int J Drug Policy"},{"key":"1385_CR32","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1477-7517-4-14","volume":"4","author":"MM Islam","year":"2007","unstructured":"Islam MM, Conigrave KM. Assessing the role of syringe dispensing machines and mobile Van outlets in reaching hard-to-reach and high-risk groups of injecting drug users (IDUs): a review. Harm Reduct J. 2007;4:14.","journal-title":"Harm Reduct J"},{"key":"1385_CR33","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1080\/10826080802344757","volume":"44","author":"MM Islam","year":"2009","unstructured":"Islam MM, Conigrave KM, Stern T. Staff perceptions of syringe dispensing machines in australia: a pilot study. Subst Use Misuse. 2009;44:490\u2013501.","journal-title":"Subst Use Misuse"},{"key":"1385_CR34","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.drugpo.2008.06.004","volume":"20","author":"D McDonald","year":"2009","unstructured":"McDonald D. The evaluation of a trial of syringe vending machines in Canberra, Australia. Int J Drug Policy. 2009;20:336\u20139.","journal-title":"Int J Drug Policy"},{"key":"1385_CR35","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1159\/000050713","volume":"7","author":"JP Moatti","year":"2001","unstructured":"Moatti JP, Vlahov D, Feroni I, Perrin V, Obadia Y. Multiple access to sterile syringes for injection drug users: vending machines, needle exchange programs and legal pharmacy sales in Marseille, France. Eur Addict Res. 2001;7:40\u20135.","journal-title":"Eur Addict Res"},{"key":"1385_CR36","unstructured":"Rife-Pennington T, Dare D, Huynh T. Implementing harm reduction vending machines in a california veterans affairs syringe services program. In AMERSA National Conference; 2023."},{"key":"1385_CR37","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12954-025-01207-x","volume":"22","author":"RQ Bryant","year":"2025","unstructured":"Bryant RQ, Reich K, Johnson JA, Delise B, Zhang Y, Lockett C, Allen ST. Drug use and harm reduction practices of applicants to a public health vending machine service in Clark County, NV, 2021\u20132023. Harm Reduct J. 2025;22:52.","journal-title":"Harm Reduct J"},{"key":"1385_CR38","doi-asserted-by":"publisher","first-page":"104709","DOI":"10.1016\/j.drugpo.2025.104709","volume":"137","author":"AM Young","year":"2025","unstructured":"Young AM, Jahangir T, Belton I, Freeman E, Livingston MD. Likelihood of using a harm reduction vending machine among rural people who inject drugs in Appalachian Kentucky. Int J Drug Policy. 2025;137:104709.","journal-title":"Int J Drug Policy"},{"key":"1385_CR39","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12954-025-01236-6","volume":"22","author":"A Zhang","year":"2025","unstructured":"Zhang A, Carrillo M, Liu R, Ballard SM, Reedy-Cooper A, Zgierska AE. Vending machines for reducing harm associated with substance use and use disorders, and co-occurring conditions: a systematic review. Harm Reduct J. 2025;22:89.","journal-title":"Harm Reduct J"},{"key":"1385_CR40","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12954-023-00765-2","volume":"20","author":"E Russell","year":"2023","unstructured":"Russell E, Johnson J, Kosinski Z, Kaplan C, Barnes N, Allen S, Haroz E. A scoping review of implementation considerations for harm reduction vending machines. Harm Reduct J. 2023;20:33.","journal-title":"Harm Reduct J"},{"key":"1385_CR41","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1016\/j.geoforum.2007.03.012","volume":"38","author":"B Tempalski","year":"2007","unstructured":"Tempalski B, Friedman R, Keem M, Cooper H, Friedman SR. NIMBY localism and National inequitable exclusion alliances: the case of syringe exchange programs in the united States. Geoforum. 2007;38:1250\u201363.","journal-title":"Geoforum"},{"key":"1385_CR42","unstructured":"NIH, national cancer institute, evidence-based cancer control programs. RE-AIM scoring instrument. [https:\/\/ebccp.cancercontrol.cancer.gov\/reAimCriteria.do]."},{"key":"1385_CR43","unstructured":"Harden S, RE-AIM workgroup. RE-AIM planning tool. [https:\/\/re-aim.org\/wp-content\/uploads\/2021\/10\/planning-tool.pdf]."},{"key":"1385_CR44","unstructured":"National cancer institute (NCI) division of cancer control and population sciences (DCCPS). Implementation science team, key leaders, RE-AIM Authors. Measuring the use of the RE-AIM model dimension items checklist. [https:\/\/re-aim.org\/wp-content\/uploads\/2016\/09\/checklistdimensions.pdf]."},{"key":"1385_CR45","unstructured":"Harden S, RE-AIM workgroup. RE-AIM coding companion guide. [https:\/\/re-aim.org\/resources-and-tools\/measures-and-checklists\/final_harden-et-al_re-aim-coding-companion-guide\/]."},{"key":"1385_CR46","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.2105\/AJPH.89.9.1322","volume":"89","author":"RE Glasgow","year":"1999","unstructured":"Glasgow RE, Vogt TM, Boles SM. Evaluating the public health impact of health promotion interventions: the RE-AIM framework. Am J Public Health. 1999;89:1322\u20137.","journal-title":"Am J Public Health"},{"key":"1385_CR47","unstructured":"University of washington supporting harm reduction programs (SHaRP) Team. Collecting demographic data at syringe services programs. 2023. [https:\/\/sites.uw.edu\/sharpta\/collecting-demographic-data ]."},{"key":"1385_CR48","unstructured":"Drug policy alliance. Core questionnaire for supervised consumption services (SCS) evaluations. Data harmonization meeting, January 11\u201312. 2018. [https:\/\/astrosstudy.org\/SCS_Core_questionnaire.pdf]."},{"key":"1385_CR49","unstructured":"European union drugs agency. Drug use disorders identification test (DUDIT) [https:\/\/www.euda.europa.eu\/drugs-library\/drug-use-disorders-identification-test-dudit_en]."},{"key":"1385_CR50","unstructured":"National insitute on drug abuse, community research branch. Risk behavior survey. [https:\/\/datashare.nida.nih.gov\/instrument\/risk-behavior-survey]."},{"key":"1385_CR51","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1521\/aeap.1996.8.2.97","volume":"8","author":"KW Smith","year":"1996","unstructured":"Smith KW, McGraw SA, Costa LA, McKinlay JB. A self-efficacy scale for HIV risk behaviors: development and evaluation. AIDS Educ Prev. 1996;8:97\u2013105.","journal-title":"AIDS Educ Prev"},{"key":"1385_CR52","doi-asserted-by":"publisher","first-page":"e0198606","DOI":"10.1371\/journal.pone.0198606","volume":"13","author":"SC Weller","year":"2018","unstructured":"Weller SC, Vickers B, Bernard HR, Blackburn AM, Borgatti S, Gravlee CC, Johnson JC. Open-ended interview questions and saturation. PLoS ONE. 2018;13:e0198606.","journal-title":"PLoS ONE"},{"key":"1385_CR53","volume-title":"StatPearls [Internet]","author":"S Tenny","year":"2022","unstructured":"Tenny S, Brannan J, Brannan G. Qualitative Study. [Updated 2022 Sep 18]. StatPearls [Internet]. Treasure Island, FL: StatPearls Publishing; 2022."},{"key":"1385_CR54","unstructured":"Survey: open-ended questions. [https:\/\/methods.sagepub.com\/ency\/edvol\/the-sage-encyclopedia-of-communication-research-methods\/chpt\/survey-openended-questions#_]."},{"key":"1385_CR55","unstructured":"Dill LJ. Engaging in qualitative research methods: opportunities for prevention and health promotion. National institutes of health, office of disease prevention. [https:\/\/prevention.nih.gov\/education-training\/methods-mind-gap\/engaging-qualitative-research-methods-opportunities-prevention-and-health-promotion]."},{"key":"1385_CR56","unstructured":"Office of policy, performance, and evaluation. Cost-benefit analysis. centers for disease control and prevention. [https:\/\/www.cdc.gov\/policy\/polaris\/economics\/cost-benefit\/index.html]."},{"key":"1385_CR57","unstructured":"CDC TRAIN. Introduction to economic evaluation in public health. The office of the associate director for policy and strategy at the centers for disease control and prevention. [https:\/\/www.train.org\/cdctrain\/welcome]."}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12954-025-01385-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-025-01385-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-025-01385-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T11:51:57Z","timestamp":1770119517000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12954-025-01385-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,4]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1385"],"URL":"https:\/\/doi.org\/10.1186\/s12954-025-01385-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7209082\/v1","asserted-by":"object"}]},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,4]]},"assertion":[{"value":"24 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21"}}